---
_schema: default
id: 88672
date: 2024-12-04
title: >-
    How does the epithelial-mesenchymal transition (EMT) relate to glycosylation changes in cancer?
article_title: >-
    How does the epithelial-mesenchymal transition (EMT) relate to glycosylation changes in cancer?
date_format: MMM DD, YYYY
post_on_text: Posted on
seo:
  title: QuickTakes | Health Studies
  page_description: >-
    This content discusses the relationship between epithelial-mesenchymal transition (EMT) and glycosylation changes in cancer, highlighting how these alterations influence cancer progression and provide insights for potential therapeutic and diagnostic approaches.
  page_keywords: >-
    epithelial-mesenchymal transition, EMT, glycosylation changes, cancer metastasis, glycosylation patterns, cell behavior, N-glycans, TGF- ligands, cell-matrix interactions, Notch ligands, glycosyltransferases, glycan-binding proteins, cancer biomarkers, cancer biology, therapeutic targets, diagnostic methods
author: QuickTakes
question: >-
    How does the epithelial-mesenchymal transition (EMT) relate to glycosylation changes in cancer?
answer: >-
    The epithelial-mesenchymal transition (EMT) is a critical process in cancer metastasis, where epithelial cells lose their characteristics and gain migratory and invasive properties typical of mesenchymal cells. This transition is closely linked to changes in glycosylation patterns, which play a significant role in regulating various aspects of cancer progression.\n\nDuring EMT, numerous carbohydrate structures undergo significant up- or down-regulation. These glycosylation changes can influence cell behavior, including proliferation, invasion, and the ability to migrate. For instance, altered N-glycans on transforming growth factor-beta (TGF-Î²) ligands can modulate cell-matrix interactions, promoting EMT. Additionally, changes in the glycosylation of Notch ligands have been shown to enhance cancer cell survival and stem cell proliferation.\n\nThe relationship between glycosylation and EMT is further underscored by the role of specific glycosyltransferases and glycan-binding proteins, which are involved in the biosynthesis of glycans that can act as cancer biomarkers. Understanding these mechanisms is crucial, as they not only provide insights into cancer biology but also open avenues for developing novel therapeutic targets and diagnostic methods.\n\nIn summary, the interplay between EMT and glycosylation changes is a vital area of research in cancer biology, highlighting how aberrant glycosylation can facilitate the metastatic process and contribute to the malignancy of tumors.
subject: Health Studies
file_name: how-does-the-epithelialmesenchymal-transition-emt-relate-to-glycosylation-changes-in-cancer.md
url: /learn/health-studies/questions/how-does-the-epithelialmesenchymal-transition-emt-relate-to-glycosylation-changes-in-cancer
score: -1.0
related_article1:
    id: 88687
    title: >-
        How does increased selectin ligand expression contribute to cancer metastasis?
    subject: Medicine
    url: /learn/medicine/questions/how-does-increased-selectin-ligand-expression-contribute-to-cancer-metastasis
related_article2:
    id: 88694
    title: >-
        How do glycosylation changes serve as cancer biomarkers?
    subject: Medicine
    url: /learn/medicine/questions/how-do-glycosylation-changes-serve-as-cancer-biomarkers
---

&nbsp;